34 studies found for:    " October 08, 2008":" November 07, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 08, 2008":" November 07, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Spatial Epidemiology of HIV Infection
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention:
2 Unknown  Directly Observed Therapy for Community-Released HIV+ Prisoners
Conditions: HIV/AIDS;   Substance Abuse
Intervention: Behavioral: Directly administered antiretroviral therapy
3 Active, not recruiting HIV Risk Reduction in Youth in the Bahamas
Condition: HIV Infections
Interventions: Behavioral: FOYC;   Behavioral: Goal for it (GFI);   Behavioral: Wonderous Wetlands;   Behavioral: Caribbean Informed Parents and Children Together (CImPACT);   Behavioral: Bahamian Focus on Older Youth (BFOOY);   Behavioral: Health and Family Life Curriculum (HFLE)
4 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
5 Completed Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 1 P inhibitor + 2 nucleoside reverse transcriptase inhibitor or 1 non-nucleoside reverse transcriptase inhibitor + 2 nucleoside reverse transcriptase inhibitor
6 Terminated
Has Results
Aspirin and Antiretroviral Therapy in HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: Aspirin 325mg;   Drug: Antiretroviral therapy (ART)
7 Completed A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence
Condition: HIV Infection
Intervention: Other: MEMS cap monitoring
8 Completed Hepatitis B and HIV Co-Infection in Patients in Uganda
Conditions: Hepatitis B;   HIV Infections
Intervention:
9 Unknown  Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
Intervention: Drug: resume raltegravir
10 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
11 Completed PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
Condition: HIV Infection
Interventions: Biological: PENNVAX-B;   Biological: GENEVAX IL-12-4532;   Biological: PLACEBO;   Biological: IL-15 adjuvant
12 Recruiting Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV
Condition: HIV Infections
Intervention:
13 Unknown  HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia
Condition: HIV Infections
Intervention:
14 Completed Healthy Teen Girls: HIV Risk Reduction
Condition: HIV-infection/Aids
Intervention: Behavioral: Cognitive-behavioral HIV/STD risk reduction
15 Terminated Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3-drug anti-HIV therapy;   Drug: Raltegravir
16 Withdrawn Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
Conditions: Hepatitis B;   Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: maraviroc;   Drug: etravirine
17 Terminated
Has Results
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency Syndrome
Interventions: Drug: Lopinavir 400 mg/ritonavir 100 mg;   Drug: Efavirenz
18 Terminated Immune Responses in Patients Treated With Raltegravir
Condition: HIV Infections
Intervention: Biological: Various vaccines
19 Unknown  An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Conditions: HIV Infection;   Tuberculosis
Intervention: Drug: Rifampin
20 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years